These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3677009)

  • 21. Parity factors and prevalence of fibrocystic breast change in a forensic autopsy series.
    Pathak DR; Pike MC; Key CR; Teaf SR; Bartow SA
    Br J Cancer; 1991 Jun; 63(6):1005-9. PubMed ID: 2069834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apocrine lesions of the breast.
    Quinn CM; D'Arcy C; Wells C
    Virchows Arch; 2022 Jan; 480(1):177-189. PubMed ID: 34537861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy.
    Hou Y; Chaudhary S; Gao FF; Li Z
    Ann Diagn Pathol; 2016 Oct; 24():4-6. PubMed ID: 27649945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients.
    Fuehrer N; Hartmann L; Degnim A; Allers T; Vierkant R; Frost M; Visscher D
    Arch Pathol Lab Med; 2012 Feb; 136(2):179-82. PubMed ID: 22288965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk of lobular-based hyperplasia after biopsy: "ductal" pattern lesions.
    Page DL; Dupont WD; Rogers LW
    Cancer Detect Prev; 1986; 9(5-6):441-8. PubMed ID: 3779706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive breast cancer risk in women with sclerosing adenosis.
    Jensen RA; Page DL; Dupont WD; Rogers LW
    Cancer; 1989 Nov; 64(10):1977-83. PubMed ID: 2804888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical staining with monoclonal Ab B72.3 in benign and malignant breast disease.
    Tavassoli FA; Jones MW; Majeste RM; Bratthauer GL; O'Leary TJ
    Am J Surg Pathol; 1990 Feb; 14(2):128-33. PubMed ID: 2301698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast.
    Tavassoli FA; Norris HJ
    Cancer; 1990 Feb; 65(3):518-29. PubMed ID: 2297643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine needle aspiration cytology of benign breast lumps: a review of experience with 651 cases.
    Jayaram G; Gupta M
    Malays J Pathol; 1994 Jun; 16(1):29-38. PubMed ID: 16329573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Carcinoma arising within mammary fibroadenomas. A study of six patients].
    Tissier F; De Roquancourt A; Astier B; Espie M; Clot P; Marty M; Janin A
    Ann Pathol; 2000 Mar; 20(2):110-4. PubMed ID: 10740004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fibrocystic disease of the breast in autopsy cases with special reference to the age frequency distribution of epithelial hyperplasia and its relation to liver cirrhosis].
    Suehiro S; Inai K; Tokuoka S
    Gan No Rinsho; 1986 Oct; 32(12):1525-32. PubMed ID: 3783977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
    Goldstein NS; O'Malley BA
    Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benign proliferative disorders of the breast.
    Ahn HJ; Cho NH; Yang WI; Choi IJ
    Yonsei Med J; 1990 Jun; 31(2):168-73. PubMed ID: 2219974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls.
    Asirvatham JR; Falcone MM; Kleer CG
    Arch Pathol Lab Med; 2016 Oct; 140(10):1045-51. PubMed ID: 27684975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When is a diagnosis of sclerosing adenosis acceptable at core biopsy?
    Gill HK; Ioffe OB; Berg WA
    Radiology; 2003 Jul; 228(1):50-7. PubMed ID: 12738875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrocystic condition and "at risk" lesions in asymptomatic breasts: a morphologic study of postmenopausal women.
    Sarnelli R; Squartini F
    Clin Exp Obstet Gynecol; 1991; 18(4):271-9. PubMed ID: 1790612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors.
    Bartow SA; Pathak DR; Mettler FA; Key CR; Pike MC
    Am J Epidemiol; 1995 Oct; 142(8):813-9. PubMed ID: 7572957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
    Cîmpean AM; Raica M; Nariţa D
    Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radial scars in women with breast cancer.
    Nielsen M; Christensen L; Andersen J
    Cancer; 1987 Mar; 59(5):1019-25. PubMed ID: 3815261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.